A pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease

Circulation

Volumn 112, Issue 7, 2005, Pages 1040-1046

  Van Royen, Niels ^a   Schirmer, Stephan H ^b   Atasever, Bektas ^a   Behrens, Casper Y H ^a   Ubbink, Dirk ^a   Buschmann, Eva E ^b   Voskuil, Michiel ^a   Bot, Pieter ^a   Hoefer, Imo ^b   Schlingemann, Reinier O ^a   Biemond, Bart J ^a   Tijssen, J G ^a   Bode, Christoph ^b   Schaper, Wolfgang ^c   Oskam, Jacques ^d   Legemate, Dink A ^a   Piek, Jan J ^a   Buschmann, Ivo ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d RIJNLAND HOSPITAL   (Netherlands)

Author keywords

Angiogenesis; Collateral circulation; Growth substances; Leukocytes; Peripheral vascular disease

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANGIOGENESIS; ANKLE BRACHIAL INDEX; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; HYPERHIDROSIS; INTERMITTENT CLAUDICATION; LASER DOPPLER FLOWMETRY; LEUKOCYTE COUNT; MALE; MICROCIRCULATION; MICROCIRCULATORY FLOW RESERVE; MYALGIA; NAUSEA; PATIENT SELECTION; PERIPHERAL CIRCULATION; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TIME; WALKING; WALKING DISTANCE; WALKING TIME; ARTERY; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; EXERCISE TEST; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; SKIN; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CORONARY ARTERY BYPASS; EXERCISE TEST; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INJECTIONS, SUBCUTANEOUS; PILOT PROJECTS; PLACEBOS; SKIN; WALKING;

EID: 23844487426     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.529552     Document Type: Article

References (22)

1. Frye RL, Gura GM, Chesebro JH, Ritman EL. Complete occlusion of the left main coronary artery and the importance of coronary collateral circulation. Mayo Clin Proc. 1977;52:742-745.
2. Ward DE, Valantine H, Hui W. Occluded left main stem coronary artery: report of five patients and review of published reports. Br Heart J. 1983;49:276-279.
3. Matsi PJ, Manninen HI, Soder HK, Mustonen P, Kouri J. Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin Radiol. 1995;50:237-244.
4. Dean SM. Pharmacologic treatment for intermittent claudication. Vasc Med. 2002;7:301-309.
5. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001;49:543-553,
6. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. 2003;23:1143-1151.
7. Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis. 2001;159:343-356.
8. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet P-A, Windecker S, Eberli FR, Meier B. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 2001;104:2012-2017.
9. van Royen N, Piek JJ, Legemate DA, Schaper W, Oskam J, Atasever B, Voskuil M, Ubbink D, Schirmer SH, Buschmann I, Bode C, Buschmann EE. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease: a randomized, double-blind, placebo-controlled trial. Vasc Med. 2003;8:191-196.
10. Ubbink DT. Toe blood pressure measurements in patients suspected of leg ischaemia: a new laser Doppler device compared with photoplethysmography. Eur J Vasc Endovasc Surg. 2004;27:629-634.
11. Ubbink DT, Jacobs MJ, Tangelder GJ. Slaaf DW, Reneman RS. The usefulness of capillary microscopy, transcutaneous oximetry and laser Doppler fluxmetry in the assessment of the severity of lower limb ischaemia. Int J Microcirc Clin Exp. 1994;14:34-44.
12. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, Annex BH. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002;359:2053-2058.
13. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164-1169.
14. Schirmer SH, van Royen N. Stimulation of collateral artery growth: a potential treatment for peripheral artery disease. Exp Rev Cardiovasc Ther. 2004;2:581-588.
15. Rajagopalan S, Mohler ER III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH. Regional Angiogenesis with Vascular Endothelial Growth Factor in Peripheral Arterial Disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108:1933-1938.
16. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-583.
17. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
18. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation. 2002;105:1639-1641.
19. van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 2002;16:432-434.
20. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9:604-613.
21. Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M, Grundmann S, Voskuil M, Ozaki CK, Piek JJ, Buschmann IR. Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ Res. 2004;94:1179-1185. Epub 2004 Apr 01.
22. van Royen N, Voskuil M, Hoefer T, Jost M, de Graaf S, Hedwig F, Andert JP, Wormhoudt TA, Hua J, Hartmann S, Bode C, Buschmann I, Schaper W, van der Neut R, Piek JJ, Pals ST. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization. Circulation. 2004;109:1647-1652.